Eurofins Calixar Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

Eurofins Calixar General Information

Description

Operator of a biotechnology company intended to preserve the original structure and function of membrane protein operations. The company engages in the production, extraction, stabilization, purification, and crystallization of functional membrane proteins and antigens, by isolating them in a native conformation without mutations or deletions, enabling biotechnology companies to develop conformational antibodies and formulate new vaccines efficiently.

Contact Information

Website
www.calixar.com
Formerly Known As
Calixar
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Bâtiment Laennec
  • 60A Avenue Rockefeller
  • 69008 Lyon
  • France
+33 04
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Bâtiment Laennec
  • 60A Avenue Rockefeller
  • 69008 Lyon
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eurofins Calixar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 23-Apr-2023 Completed Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 13-Mar-2020 Completed Generating Revenue
5. Early Stage VC (Series A) 24-Feb-2015 Completed Generating Revenue
4. Secondary Transaction - Private 17-Oct-2014 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Jun-2012 $1.1M $1.1M Completed Generating Revenue
1. Early Stage VC 01-Jan-2011 Completed Startup
To view Eurofins Calixar’s complete valuation and funding history, request access »

Eurofins Calixar Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A Preference
Ordinary
Class A Preference 33,400 $1.134983 $28.37 $28.37 1x $28.37 28.17%
To view Eurofins Calixar’s complete cap table history, request access »

Eurofins Calixar Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to preserve the original structure and function of membrane protein operati
Drug Discovery
Lyon, France
13 As of 2026

Centennial, CO

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eurofins Calixar Competitors (3)

One of Eurofins Calixar’s 3 competitors is Novus Biologicals, a Formerly PE-Backed company based in Centennial, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novus Biologicals Formerly PE-Backed Centennial, CO
Cusabio Corporation Houston, TX
BioLegend Formerly Accelerator/Incubator backed San Diego, CA
You’re viewing 3 of 3 competitors. Get the full list »

Eurofins Calixar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eurofins Calixar Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ad-hoc Invest Angel Group Minority
Banque Populaire Corporation Minority
Bpifrance Sovereign Wealth Fund Minority
Crealys Venture Capital Minority
Grenoble Angels Angel Group Minority
You’re viewing 5 of 12 investors. Get the full list »

Eurofins Calixar FAQs

  • When was Eurofins Calixar founded?

    Eurofins Calixar was founded in 2011.

  • Where is Eurofins Calixar headquartered?

    Eurofins Calixar is headquartered in Lyon, France.

  • What is the size of Eurofins Calixar?

    Eurofins Calixar has 13 total employees.

  • What industry is Eurofins Calixar in?

    Eurofins Calixar’s primary industry is Drug Discovery.

  • Is Eurofins Calixar a private or public company?

    Eurofins Calixar is a Private company.

  • What is Eurofins Calixar’s current revenue?

    The current revenue for Eurofins Calixar is .

  • How much funding has Eurofins Calixar raised over time?

    Eurofins Calixar has raised $4.99M.

  • Who are Eurofins Calixar’s investors?

    Ad-hoc Invest, Banque Populaire, Bpifrance, Crealys, and Grenoble Angels are 5 of 12 investors who have invested in Eurofins Calixar.

  • Who are Eurofins Calixar’s competitors?

    Novus Biologicals, Cusabio, and BioLegend are competitors of Eurofins Calixar.

  • When was Eurofins Calixar acquired?

    Eurofins Calixar was acquired on 23-Apr-2023.

  • Who acquired Eurofins Calixar?

    Eurofins Calixar was acquired by Eurofins Discovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process